Patents by Inventor Duncan Smith

Duncan Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7359394
    Abstract: A network layer bridge for connection between network segments with different data link layer addressing. The bridge has includes: plurality of ports, each for connection to different network segments, wherein a first port is for connection to a first network segment and a second port for connection to respective first and second network segment. The bridge also has a memory for storing network layer addresses, for nodes together with corresponding port identifiers and data link layer addresses, and the memory is adapted to store data link layer addresses of more than one type; the bridge also has a means for and a unit for discovering corresponding port identifier and data link layer address for a network layer address. For which these are not already known.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: April 15, 2008
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: David Banks, Duncan Smith, Anthony John Wiley
  • Publication number: 20070265248
    Abstract: Selected substituted piperazine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
    Type: Application
    Filed: April 27, 2005
    Publication date: November 15, 2007
    Applicant: Amgen Inc.
    Inventors: Christopher Fotsch, Premilla Arasasingham, Yunxin Bo, Ning Chen, Martin Goldberg, Nianhe Han, Feng-Yin Hsieh, Michael Kelly, Qingyian Liu, Mark Norman, Duncan Smith, Markian Stec, Nuria Tamayo, Ning Xi, Shimin Xu, Elizabeth Doherty
  • Publication number: 20060190561
    Abstract: A web crawler system has an automatic website crawler and a virtual browser that provides script related information to the website crawler. The virtual browser transforms an HTML document included in a web page of the website into an XML document, and builds a document object model containing document objects in a tree structure based on the XML document. The virtual browser extracts from the DOM scripts that are potentially executable, and executes the extracted scripts using a browser object model provided for the virtual browser containing objects and methods and properties that are used for script execution so as to capture script related information generated by execution of the scripts.
    Type: Application
    Filed: March 3, 2006
    Publication date: August 24, 2006
    Applicant: Watchfire Corporation
    Inventors: Craig Conboy, Darcy Chorneyko, Derek McDougall, Constantine Grancharov, Andrew Rolleston, Duncan Smith
  • Patent number: 7022727
    Abstract: The present invention relates to a crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-?-D-ribofuranosyluronamide)-N-(2-{N?-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide and to a process for the preparation of, compositions containing and the uses of such a crystalline form.
    Type: Grant
    Filed: September 3, 2004
    Date of Patent: April 4, 2006
    Assignee: Pfizer Inc
    Inventors: Terence Vernon Silk, Julian Duncan Smith
  • Patent number: 6852746
    Abstract: The present invention relates to a crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-?-D-ribofuranosyluronamide)-N-(2-{N?-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide and to a process for the preparation of, compositions containing and the uses of such a crystalline form.
    Type: Grant
    Filed: December 3, 2002
    Date of Patent: February 8, 2005
    Assignee: Pfizer Inc
    Inventors: Terence Vernon Silk, Julian Duncan Smith
  • Publication number: 20040143787
    Abstract: A system and method are disclosed for resolving Universal Resource Locators (URLs). The URL resolving system examines the script code to obtain URLs from the examination output in the context of website crawling.
    Type: Application
    Filed: June 19, 2002
    Publication date: July 22, 2004
    Inventors: Constantine Grancharov, Andrew Rolleston, Duncan Smith
  • Publication number: 20040109460
    Abstract: A network layer bridge for connection between network segments with different data link layer addressing. The bridge has a plurality of ports, each for connection to a different network segment, wherein a first port is for connection to a first network segment and a second port is for connection to a second network segment. The bridge also has a memory for storing network layer addresses for nodes together with corresponding port identifiers and data link layer addresses, and the memory is adapted to store data link layer addresses of more than one type. The bridge also has a means for discovering corresponding port identifier and data link layer address for a network layer address for which these are not already known.
    Type: Application
    Filed: August 15, 2003
    Publication date: June 10, 2004
    Applicant: HEWLETT-PACKARD COMPANY
    Inventors: David Banks, Duncan Smith, Anthony John Wiley
  • Patent number: 6747979
    Abstract: A network layer bridge includes: plurality of ports for connection to different network segments, a first port and a second port for connection to respective first and second network segments; a memory for storing network layer addresses for nodes with corresponding port identifiers and data link layer addresses, and data link layer addresses of more than one type; and a unit for discovering corresponding port identifier and data link layer address for a network layer address. The bridge forwards a message from a first node to a second node when corresponding port identifiers and data link level addresses for both first and second nodes are stored in the memory; the message being addressed with the network layer address of the second node, and the network layer bridge directing the message through the corresponding port to the corresponding data link level address for the second node.
    Type: Grant
    Filed: October 27, 1999
    Date of Patent: June 8, 2004
    Assignee: Hewlett-Packard Development Company, L.C.
    Inventors: David Banks, Duncan Smith, Anthony John Wiley
  • Patent number: 6610711
    Abstract: Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R1, R2, R3, W, Y1, Y2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment of pruritic dermatoses including allergic dermatitis and atopy in animals and humans.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: August 26, 2003
    Assignee: Pfizer Inc.
    Inventors: Richard Edward Armer, Christopher James Dutton, David Morris Gethin, Stephen Paul Gibson, Julian Duncan Smith, Ivan Tommasini
  • Publication number: 20030158145
    Abstract: The present invention relates to a crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-&bgr;-D-ribofuranosyluronamide)-N-(2-{N′-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide and to a process for the preparation of, compositions containing and the uses of such a crystalline form.
    Type: Application
    Filed: December 3, 2002
    Publication date: August 21, 2003
    Inventors: Terence Vernon Silk, Julian Duncan Smith
  • Publication number: 20030144243
    Abstract: The present invention relates to a combination of a crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-&bgr;-D-ribofuranosyluronamide)-N-(2-{N′-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide and a tiotropium salt. Such a combination is useful in the treatment of respiratory diseases such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: December 3, 2002
    Publication date: July 31, 2003
    Inventors: Terrence Vernon Silk, Julian Duncan Smith
  • Publication number: 20030078282
    Abstract: Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R 1, R 2, R 3, W, Y 1, Y 2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment.
    Type: Application
    Filed: May 11, 2000
    Publication date: April 24, 2003
    Inventors: Richard Edward Armer, Christopher James Dutton, David Morris Gethin, Stephen Paul Gibson, Julian Duncan Smith, Ivan Tommasini
  • Patent number: 6417203
    Abstract: Compounds of formula (I): are antithrombotic agents, having utility in a variety of therapeutic areas including the prevention and/or treatment of deep vein thrombosis (DVT) after surgery, major medical illness, paralysis, malignancy, prolonged immobilisation trauma, application of lower limb plaster casts, or fractures of the lower limbs or pelvis; recurrent DVT; DVT during pregnancy when there is a previous history thereof; reocclusion following thrombolytic therapy; chronic arterial obstruction; peripheral vascular disease; acute myocardial infarction; unstable angina; atrial fibrillation; thrombotic stroke; transient ischaemic attacks; disseminated intravascular coagulation; coagulation in extra-corporeal circuits; occlusion of arterio-venous shunts and blood vessel grafts (including coronary artery by-pass grafts); and restenosis and occlusion following angioplasty.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: July 9, 2002
    Assignee: Pfizer Inc.
    Inventors: Julian Blagg, Alan Daniel Brown, Elisabeth Colette Louise Gautier, Julian Duncan Smith, Andrew Brian McElroy
  • Patent number: 6180627
    Abstract: Compounds of formula (I): Are antithrombotic agents, having utility in a variety of therapeutic areas including the prevention and/or treatment of deep vein thrombosis (DVT) after surgery, major medical illness, paralysis, malignancy, prolonged immobilisation trauma, application of lower limb plaster casts, or fractures of the lower limbs or pelvis; recurrent DVT; DVT during pregnancy when there is a previous history thereof; reocclusion following thrombolytic therapy; chronic arterial obstruction; peripheral vascular disease; acute myocardial infarction; unstable angina; atrial fibrillation; thrombotic stroke; transient ischaemic attacks; disseminated intravascular coagulation; coagulation in extra-corporeal circuits; occlusion of aterio-venous shunts and blood vessel grafts (including coronary artery by-pass grafts); and restenosis and occlusion following angioplasty.
    Type: Grant
    Filed: August 11, 1999
    Date of Patent: January 30, 2001
    Assignee: Pfizer Inc.
    Inventors: Julian Blagg, Alan Daniel Brown, Elisabeth Colette Louise Gautier, Julian Duncan Smith, Andrew Brian McElroy
  • Patent number: 6018571
    Abstract: An interactive system include a software application and a telephone which function cooperatively to implement a multiplicity of user-invoked features. The telephone set is connected to a computer on which a telephony application program interface application is executed. The telephone set includes a plurality of user-definable function keys in addition to the standard keypad, handset, speaker phone and other standard components. The user-definable function keys are programmable via the computer to implement telephony features or to launch applications on the computer.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: January 25, 2000
    Assignee: Mitel Corporation
    Inventors: Michael Langlois, Richard Loen, Duncan Smith, Michael Lahrkamp, Paul Chehowski, Peter Couse